In order to identify the pivotal genes in regulating CRG subgroup division and tumor-immunity-mediated drug sensitivity change, an importance analysis is performed, and it shows CDKN2A is the most important gene (Figure 12A). The gene discussed is CDKN2A; the disease is neoplasm.